Renal sympathetic denervation for treatment of patients with heart failure: summary of the available evidence

References

• Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation. 1993;88:136–45.
   PubMed Web of Science ®Google Scholar
• Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994;23:570–8.
   PubMed Web of Science ®Google Scholar
• Mann DL, Kent RL, Parsons B, Cooper G. IV Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992;85:790–804.
   PubMed Web of Science ®Google Scholar
• Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003;108:560–5.
   PubMed Web of Science ®Google Scholar
• Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257–63.
   PubMed Web of Science ®Google Scholar
• Packer M, Bristow MR, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349–55.
   PubMed Web of Science ®Google Scholar
• CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomized trial. Lancet. 1999;353:9–13.
   PubMed Web of Science ®Google Scholar
• Cohn JN, Pfeffer MA, Rouleau J, Sharpe N, Swedberg K, Straub M, et al. Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON). Eur J Heart Fail. 2003;5:659–67.
   PubMed Web of Science ®Google Scholar
• Petersson M, Friberg P, Eisenhofer G, Lambert G, Rundqvist B. Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J. 2005;26:906–13.
   PubMed Web of Science ®Google Scholar
• Esler M. The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol. 2010;108:227–37.
   PubMed Web of Science ®Google Scholar
• Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Böhm M, Krum H. Sympatho-renal axis in chronic disease. Clin Res Cardiol. 2011;100:1049–57.
   PubMed Web of Science ®Google Scholar
• Hering D, Esler MD, Krum H, Mahfoud F, Böhm M, Sobotka PA, et al. Recent advances in the treatment of hypertension. Expert Rev Cardiovasc Ther. 2011;9:729–44.
   PubMedGoogle Scholar
• Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M. Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation. 2011;123:209–15.
   PubMed Web of Science ®Google Scholar
• Schlaich MP, Hering D, Sobotka PA, Krum H, Esler MD. Renal denervation in human hypertension: mechanisms, current findings, and future prospects. Curr Hypertens Rep. 2012;14:247–53.
   PubMed Web of Science ®Google Scholar
• Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995;25:878–82.
   PubMed Web of Science ®Google Scholar
• Gattone VHII, Siqueira TM Jr, Powell CR, Trambaugh CM, Lingeman JE, Shalhav AL. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease. Exp Biol Med. 2008;233:952–7.
   Web of Science ®Google Scholar
• Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912–18.
   PubMed Web of Science ®Google Scholar
• Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, et al. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002;106:1974–9.
   PubMed Web of Science ®Google Scholar
• Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, et al. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension. 2013;61:457–64.
   PubMed Web of Science ®Google Scholar
• Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, et al. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension. Hypertension. 2014;64:118–24.
   PubMed Web of Science ®Google Scholar
• Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, et al. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension. Clin Res Cardiol. 2016;105:364–71.
   PubMed Web of Science ®Google Scholar
• Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, et al. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension. Int J Cardiol. 2013;169:418–24.
   PubMed Web of Science ®Google Scholar
• Brooks WW, Conrad CH. Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates. Comp Med. 2009;59:339–43.
   PubMed Web of Science ®Google Scholar
• Sumita Yoshikawa W, Nakamura K, Miura D, Shimizu J, Hashimoto K, Kataoka N, et al. Increased passive stiffness of cardiomyocytes in the transverse direction and residual actin and myosin cross-bridge formation in hypertrophied rat hearts induced by chronic β-adrenergic stimulation. Circ J. 2013;77:741–8.
   PubMed Web of Science ®Google Scholar
• Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Arenare F, Spaziani D, et al. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction. Hypertension. 2009;53:205–9.
   PubMed Web of Science ®Google Scholar
• Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724–9.
   PubMed Web of Science ®Google Scholar
• Nozawa T, Igawa A, Fujii N, Kato B, Yoshida N, Asanoi H, et al. Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats. Heart Vessel. 2002;16:51–6.
   PubMed Web of Science ®Google Scholar
• Hu J, Li Y, Cheng W, Yang Z, Wang F, Lv P, et al. A comparison of the efficacy of surgical renal denervation and pharmacologic therapies in post-myocardial infarction heart failure. PLoS One. 2014;9:e96996.
   Google Scholar
• Hu J, Ji M, Niu C, Aini A, Zhou Q, Zhang L, et al. Effects of renal sympathetic denervation on post-myocardial infarction cardiac remodeling in rats. PLoS One. 2012;7:e45986.
   Google Scholar
• Hu J, Yan Y, Zhou Q, Ji M, Niu C, Hou Y, et al. Effects of renal denervation on the development of post-myocardial infarction heart failure and cardiac autonomic nervous system in rats. Int J Cardiol. 2014;172:e414–16.
   Google Scholar
• Zheng H, Liu X, Sharma NM, Patel KP. Renal denervation improves cardiac function in rats with heart failure: effects on expression of β-adrenoceptors. Am J Physiol Heart Circ Physiol. 2016;311:H337–46.
   Google Scholar
• Liu Q, Lu D, Wang S, Wang K, Zhang Q, Wang Y, et al. Renal denervation significantly attenuates cardiorenal fibrosis in rats with sustained pressure overload. J Am Soc Hypertens. 2016;10:587–96.
   PubMed Web of Science ®Google Scholar
• Li ZZ, Jiang H, Chen D, Liu Q, Geng J, Guo JQ, et al. Renal sympathetic denervation improves cardiac dysfunction in rats with chronic pressure overload. Physiol Res. 2015;64:653–62.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhang Q, Wang K, Wang S, Lu D, Li Z, et al. Renal denervation findings on cardiac and renal fibrosis in rats with isoproterenol induced cardiomyopathy. Sci Rep. 2015;5:18582.
   PubMed Web of Science ®Google Scholar
• Clayton SC, Haack KK, Zucker IH. Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure. Am J Physiol Renal Physiol. 2011;300:F31–9.
   PubMedGoogle Scholar
• Schiller AM, Haack KK, Pellegrino PR, Curry PL, Zucker IH. Unilateral renal denervation improves autonomic balance in conscious rabbits with chronic heart failure. Am J Physiol Regul Integr Comp Physiol. 2013;305:R886–92.
   Google Scholar
• Zhao Q, Huang H, Wang X, Wang X, Dai Z, Wan P, et al. Changes of serum neurohormone after renal sympathetic denervation in dogs with pacing-induced heart failure. Int J Clin Exp Med. 2014;7:4024–30.
   PubMed Web of Science ®Google Scholar
• Dai Z, Yu S, Zhao Q, Meng Y, He H, Tang Y, et al. Renal sympathetic denervation suppresses ventricular substrate remodelling in a canine high-rate pacing model. EuroIntervention. 2014;10:392–9.
   PubMed Web of Science ®Google Scholar
• Guo Z, Zhao Q, Deng H, Tang Y, Wang X, Dai Z, et al. Renal sympathetic denervation attenuates the ventricular substrate and electrophysiological remodeling in dogs with pacing-induced heart failure. Int J Cardiol. 2014;175:185–6.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Yu S, Huang H, Tang Y, Xiao J, Dai Z, et al. Effects of renal sympathetic denervation on the development of atrial fibrillation substrates in dogs with pacing-induced heart failure. Int J Cardiol. 2013;168:1672–3.
   PubMed Web of Science ®Google Scholar
• Booth LC, Schlaich MP, Nishi EE, Yao ST, Xu J, Ramchandra R, et al. Short-term effects of catheter-based renal denervation on cardiac sympathetic drive and cardiac baroreflex function in heart failure. Int J Cardiol. 2015;190:220–6.
   PubMed Web of Science ®Google Scholar
• Xie Y, LiuLiu Q, Xu Y, Gao J, Yan P, Zhang W, et al. Effect of catheter-based renal sympathetic denervation in pigs with rapid pacing induced heart failure. Zhonghua Xin Xue Guan Bing Za Zhi. 2014;42:48–52.
   PubMedGoogle Scholar
• Torp M, Brønd L, Nielsen JB, Nielsen S, Christensen S, Jonassen TE. Effects of renal denervation on the NKCC2 cotransporter in the thick ascending limb of the loop of Henle in rats with congestive heart failure. Acta Physiol (Oxf). 2012;204:451–9.
   PubMed Web of Science ®Google Scholar
• Foss JD, Wainford RD, Engeland WC, Fink GD, Osborn JW. A novel method of selective ablation of afferent renal nerves by periaxonal application of capsaicin. Am J Physiol Regul Integr Comp Physiol. 2015;308:R112–22.
   PubMed Web of Science ®Google Scholar
• Booth LC, Nishi EE, Yao ST, Ramchandra R, Lambert GW, Schlaich MP, et al. Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep. Hypertension. 2015;65:393–400.
   PubMed Web of Science ®Google Scholar
• Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, Mayet J, et al. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-pilot study. Int J Cardiol. 2013;162:189–92.
   PubMed Web of Science ®Google Scholar
• Dai Q, Lu J, Wang B, Ma G. Effect of percutaneous renal sympathetic nerve radiofrequency ablation in patients with severe heart failure. Int J Clin Exp Med. 2015;8:9779–85.
   PubMed Web of Science ®Google Scholar
• Chen W, Ling Z, Xu Y, Liu Z, Su L, Du H, Xiao P, Lan X, Shan Q, Yin Y. Preliminary effects of renal denervation with saline irrigated catheter on cardiac systolic function in patients with heart failure: A Prospective, Randomized, Controlled, Pilot Study. Catheter Cardiovasc Interv. 2016, in press. doi: 10.1002/ccd.26475.
   Web of Science ®Google Scholar
• Taborsky M, Lazarova M, Vaclavik J, Richter D, The effect of renal denervation in patients with advanced heart failure: the OLOMOUC I study. Proceedings of the European Society of Cardiology Congress; August 2012; Munich, Germany. “Abstract”.
   Google Scholar
• Ukena C, Mahfoud F, Ewen S, Bollmann A, Hindricks G, Hoffmann BA, et al. Renal denervation for treatment of ventricular arrhythmias: data from an International Multicenter Registry. Clin Res Cardiol. 2016;105:873–9.
   PubMed Web of Science ®Google Scholar
• Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M, et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012;59:901–9.
   PubMed Web of Science ®Google Scholar
• Schirmer SH, Sayed MM, Reil JC, Ukena C, Linz D, Kindermann M, et al. Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction. J Am Coll Cardiol. 2014;63:1916–23.
   PubMed Web of Science ®Google Scholar
• Mahfoud F, Urban D, Teller D, Linz D, Stawowy P, Hassel JH, et al. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J. 2014;35:2224–31b.
   PubMed Web of Science ®Google Scholar
• Patel HC, Rosen SD, Hayward C, Vassiliou V, Smith GC, Wage RR, et al. Renal denervation in heart failure with preserved ejection fraction (RDT-PEF): a randomized controlled trial. Eur J Heart Fail. 2016;18:703–12.
   PubMed Web of Science ®Google Scholar
• de Sousa Almeida M, de Araújo Gonçalves P, Branco P, Mesquita J, Carvalho MS, Dores H, et al. Impact of renal sympathetic denervation on left ventricular structure and function at 1-year follow-up. PLoS One. 2016;11:e0149855.
   PubMed Web of Science ®Google Scholar
• Verloop WL, Beeftink MM, Nap A, Bots ML, Velthuis BK, Appelman YE, et al. Renal denervation in heart failure with normal left ventricular ejection fraction. Rationale and design of the DIASTOLE (DenervatIon of the renAl Sympathetic nerves in hearT failure with nOrmal Lv Ejection fraction) trial. Eur J Heart Fail. 2013;15:1429–37.
   PubMed Web of Science ®Google Scholar
• Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–9.
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Kandzari DE, O’Neill WW, D'Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393–401.
   PubMed Web of Science ®Google Scholar
• Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, et al. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Hypertension. 2014;63:991–9.
   PubMed Web of Science ®Google Scholar
• Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet. 2015;385:1957–65.
   PubMed Web of Science ®Google Scholar
• Rosa J, Widimský P, Toušek P, Petrák O, Čurila K, Waldauf P, et al. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study. Hypertension. 2014;65:407–13.
   PubMed Web of Science ®Google Scholar
• Desch S, Okon T, Heinemann D, Kulle K, Röhnert K, Sonnabend M, et al. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension. Hypertension. 2015;65:1202–8.
   PubMed Web of Science ®Google Scholar
• Kario K, Ogawa H, Okumura K, Okura T, Saito S, Ueno T, et al. First randomized controlled trial of catheter-based renal denervation in Asian patients. Circ J. 2015;79:1222–9.
   PubMed Web of Science ®Google Scholar
• Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, et al. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol. 2014;64:1071–8.
   PubMed Web of Science ®Google Scholar
• Fadl Elmula FE, Jin Y, Yang WY, Thijs L, Lu YC, Larstorp AC, et al. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension. Blood Press. 2015;24:263–74.
   PubMed Web of Science ®Google Scholar